Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy

Is gastroparesis a factor?

Anna Tavakkoli, Bisma A. Sayed, Nicholas J. Talley, Baharak Moshiree

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Aim: To determine whether an increased number and duration of non-acid reflux events as measured using the multichannel intraluminal impedance pH (MII-pH) is linked to gastroparesis (GP). Methods: A case control study was conducted in which 42 patients undergoing clinical evaluation for continued symptoms of gastroesophageal reflux disease (both typical and atypical symptoms) despite acid suppression therapy. MII-pH technology was used over 24 h to detect reflux episodes and record patients' symptoms. Parameters evaluated in patients with documented GP and controls without GP by scintigraphy included total, upright, and supine number of acid and non-acid reflux episodes (pH < 4 and pH > 4, respectively), the duration of acid and non-acid reflux in a 24-h period, and the number of reflux episodes lasting longer than 5 min. Results: No statistical difference was seen between the patients with GP and controls with respect to the total number or duration of acid reflux events, total number and duration of non-acid reflux events or the duration of longest reflux episodes. The number of nonacid reflux episodes with a pH > 7 was higher in subjects with GP than in controls. In addition, acid reflux episodes were more prolonged (lasting longer than 5 min) in the GP patients than in controls; however, these values did not reach statistical significance. Thirty-five patients had recorded symptoms during the 24 h study and of the 35 subjects, only 9% (n = 3) had a positive symptom association probability (SAP) for acid/non-acid reflux and 91% had a negative SAP. Conclusion: The evaluation of patients with a documented history of GP did not show an association between GP and more frequent episodes of non-acid reflux based on MII-pH testing.

Original languageEnglish
Pages (from-to)6193-6198
Number of pages6
JournalWorld Journal of Gastroenterology
Volume19
Issue number37
DOIs
StatePublished - Oct 7 2013

Fingerprint

Gastroparesis
Proton Pump Inhibitors
Acids
Electric Impedance
Therapeutics
Symptom Assessment
Gastroesophageal Reflux
Radionuclide Imaging
Case-Control Studies
Technology

Keywords

  • Acid gastroesophageal reflux
  • Functional bowel disorder
  • Gastroparesis
  • Multi-channel intraluminal impedance
  • Non-acid gastroesophageal reflux

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy : Is gastroparesis a factor? / Tavakkoli, Anna; Sayed, Bisma A.; Talley, Nicholas J.; Moshiree, Baharak.

In: World Journal of Gastroenterology, Vol. 19, No. 37, 07.10.2013, p. 6193-6198.

Research output: Contribution to journalArticle

Tavakkoli, Anna ; Sayed, Bisma A. ; Talley, Nicholas J. ; Moshiree, Baharak. / Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy : Is gastroparesis a factor?. In: World Journal of Gastroenterology. 2013 ; Vol. 19, No. 37. pp. 6193-6198.
@article{2fce63315b8d4a7981f21a28d16250f2,
title = "Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy: Is gastroparesis a factor?",
abstract = "Aim: To determine whether an increased number and duration of non-acid reflux events as measured using the multichannel intraluminal impedance pH (MII-pH) is linked to gastroparesis (GP). Methods: A case control study was conducted in which 42 patients undergoing clinical evaluation for continued symptoms of gastroesophageal reflux disease (both typical and atypical symptoms) despite acid suppression therapy. MII-pH technology was used over 24 h to detect reflux episodes and record patients' symptoms. Parameters evaluated in patients with documented GP and controls without GP by scintigraphy included total, upright, and supine number of acid and non-acid reflux episodes (pH < 4 and pH > 4, respectively), the duration of acid and non-acid reflux in a 24-h period, and the number of reflux episodes lasting longer than 5 min. Results: No statistical difference was seen between the patients with GP and controls with respect to the total number or duration of acid reflux events, total number and duration of non-acid reflux events or the duration of longest reflux episodes. The number of nonacid reflux episodes with a pH > 7 was higher in subjects with GP than in controls. In addition, acid reflux episodes were more prolonged (lasting longer than 5 min) in the GP patients than in controls; however, these values did not reach statistical significance. Thirty-five patients had recorded symptoms during the 24 h study and of the 35 subjects, only 9{\%} (n = 3) had a positive symptom association probability (SAP) for acid/non-acid reflux and 91{\%} had a negative SAP. Conclusion: The evaluation of patients with a documented history of GP did not show an association between GP and more frequent episodes of non-acid reflux based on MII-pH testing.",
keywords = "Acid gastroesophageal reflux, Functional bowel disorder, Gastroparesis, Multi-channel intraluminal impedance, Non-acid gastroesophageal reflux",
author = "Anna Tavakkoli and Sayed, {Bisma A.} and Talley, {Nicholas J.} and Baharak Moshiree",
year = "2013",
month = "10",
day = "7",
doi = "10.3748/wjg.v19.i37.6193",
language = "English",
volume = "19",
pages = "6193--6198",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "37",

}

TY - JOUR

T1 - Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy

T2 - Is gastroparesis a factor?

AU - Tavakkoli, Anna

AU - Sayed, Bisma A.

AU - Talley, Nicholas J.

AU - Moshiree, Baharak

PY - 2013/10/7

Y1 - 2013/10/7

N2 - Aim: To determine whether an increased number and duration of non-acid reflux events as measured using the multichannel intraluminal impedance pH (MII-pH) is linked to gastroparesis (GP). Methods: A case control study was conducted in which 42 patients undergoing clinical evaluation for continued symptoms of gastroesophageal reflux disease (both typical and atypical symptoms) despite acid suppression therapy. MII-pH technology was used over 24 h to detect reflux episodes and record patients' symptoms. Parameters evaluated in patients with documented GP and controls without GP by scintigraphy included total, upright, and supine number of acid and non-acid reflux episodes (pH < 4 and pH > 4, respectively), the duration of acid and non-acid reflux in a 24-h period, and the number of reflux episodes lasting longer than 5 min. Results: No statistical difference was seen between the patients with GP and controls with respect to the total number or duration of acid reflux events, total number and duration of non-acid reflux events or the duration of longest reflux episodes. The number of nonacid reflux episodes with a pH > 7 was higher in subjects with GP than in controls. In addition, acid reflux episodes were more prolonged (lasting longer than 5 min) in the GP patients than in controls; however, these values did not reach statistical significance. Thirty-five patients had recorded symptoms during the 24 h study and of the 35 subjects, only 9% (n = 3) had a positive symptom association probability (SAP) for acid/non-acid reflux and 91% had a negative SAP. Conclusion: The evaluation of patients with a documented history of GP did not show an association between GP and more frequent episodes of non-acid reflux based on MII-pH testing.

AB - Aim: To determine whether an increased number and duration of non-acid reflux events as measured using the multichannel intraluminal impedance pH (MII-pH) is linked to gastroparesis (GP). Methods: A case control study was conducted in which 42 patients undergoing clinical evaluation for continued symptoms of gastroesophageal reflux disease (both typical and atypical symptoms) despite acid suppression therapy. MII-pH technology was used over 24 h to detect reflux episodes and record patients' symptoms. Parameters evaluated in patients with documented GP and controls without GP by scintigraphy included total, upright, and supine number of acid and non-acid reflux episodes (pH < 4 and pH > 4, respectively), the duration of acid and non-acid reflux in a 24-h period, and the number of reflux episodes lasting longer than 5 min. Results: No statistical difference was seen between the patients with GP and controls with respect to the total number or duration of acid reflux events, total number and duration of non-acid reflux events or the duration of longest reflux episodes. The number of nonacid reflux episodes with a pH > 7 was higher in subjects with GP than in controls. In addition, acid reflux episodes were more prolonged (lasting longer than 5 min) in the GP patients than in controls; however, these values did not reach statistical significance. Thirty-five patients had recorded symptoms during the 24 h study and of the 35 subjects, only 9% (n = 3) had a positive symptom association probability (SAP) for acid/non-acid reflux and 91% had a negative SAP. Conclusion: The evaluation of patients with a documented history of GP did not show an association between GP and more frequent episodes of non-acid reflux based on MII-pH testing.

KW - Acid gastroesophageal reflux

KW - Functional bowel disorder

KW - Gastroparesis

KW - Multi-channel intraluminal impedance

KW - Non-acid gastroesophageal reflux

UR - http://www.scopus.com/inward/record.url?scp=84885592661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885592661&partnerID=8YFLogxK

U2 - 10.3748/wjg.v19.i37.6193

DO - 10.3748/wjg.v19.i37.6193

M3 - Article

VL - 19

SP - 6193

EP - 6198

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 37

ER -